BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,140 filers reported holding BAXTER INTL INC in Q4 2021. The put-call ratio across all filers is 1.40 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $647,592 | -6.8% | 17,159,292 | +12.5% | 0.10% | -2.1% |
| Q2 2023 | $694,975 | +86.3% | 15,254,038 | +65.9% | 0.10% | +73.2% |
| Q1 2023 | $373,022 | +1016.8% | 9,196,775 | +1303.4% | 0.06% | +1020.0% |
| Q4 2022 | $33,401 | -99.9% | 655,322 | -0.4% | 0.01% | -16.7% |
| Q3 2022 | $35,439,000 | -84.2% | 657,960 | -81.1% | 0.01% | -78.6% |
| Q2 2022 | $224,131,000 | -34.6% | 3,489,509 | -21.1% | 0.03% | -20.0% |
| Q1 2022 | $342,807,000 | -18.5% | 4,421,037 | -9.8% | 0.04% | -7.9% |
| Q4 2021 | $420,582,000 | -3.0% | 4,899,602 | -9.1% | 0.04% | -7.3% |
| Q3 2021 | $433,566,000 | -1.8% | 5,390,603 | -1.7% | 0.04% | 0.0% |
| Q2 2021 | $441,493,000 | +16.2% | 5,484,387 | +21.8% | 0.04% | +7.9% |
| Q1 2021 | $379,781,000 | +32.4% | 4,502,981 | +26.0% | 0.04% | +31.0% |
| Q4 2020 | $286,863,000 | +10.9% | 3,575,066 | +11.1% | 0.03% | -3.3% |
| Q3 2020 | $258,761,000 | -7.8% | 3,217,618 | -1.3% | 0.03% | -14.3% |
| Q2 2020 | $280,761,000 | +1.9% | 3,260,873 | -3.9% | 0.04% | -20.5% |
| Q1 2020 | $275,603,000 | -12.0% | 3,394,543 | -9.3% | 0.04% | +7.3% |
| Q4 2019 | $313,025,000 | -3.6% | 3,743,425 | +0.8% | 0.04% | -10.9% |
| Q3 2019 | $324,760,000 | +6.8% | 3,712,815 | +0.0% | 0.05% | +7.0% |
| Q2 2019 | $304,021,000 | -16.4% | 3,712,096 | -17.0% | 0.04% | -18.9% |
| Q1 2019 | $363,796,000 | +2.5% | 4,474,186 | -17.1% | 0.05% | -11.7% |
| Q4 2018 | $355,084,000 | -22.6% | 5,394,776 | -9.3% | 0.06% | -10.4% |
| Q3 2018 | $458,670,000 | +4.7% | 5,949,805 | +0.3% | 0.07% | 0.0% |
| Q2 2018 | $438,105,000 | +13.9% | 5,933,165 | +0.3% | 0.07% | +9.8% |
| Q1 2018 | $384,781,000 | +1.8% | 5,916,069 | +1.1% | 0.06% | 0.0% |
| Q4 2017 | $378,163,000 | +4.3% | 5,850,295 | +1.2% | 0.06% | -1.6% |
| Q3 2017 | $362,601,000 | +1.2% | 5,778,507 | -2.3% | 0.06% | -3.1% |
| Q2 2017 | $358,175,000 | +12.3% | 5,916,338 | -3.8% | 0.06% | +6.7% |
| Q1 2017 | $319,085,000 | +21.8% | 6,152,808 | +4.2% | 0.06% | +15.4% |
| Q4 2016 | $261,937,000 | +9.3% | 5,907,468 | +17.3% | 0.05% | +8.3% |
| Q3 2016 | $239,641,000 | +7.0% | 5,034,473 | +1.6% | 0.05% | +2.1% |
| Q2 2016 | $223,989,000 | +9.8% | 4,953,318 | -0.3% | 0.05% | +6.8% |
| Q1 2016 | $203,998,000 | +22.0% | 4,965,869 | +13.3% | 0.04% | +25.7% |
| Q4 2015 | $167,182,000 | +390.6% | 4,382,239 | +322.4% | 0.04% | +337.5% |
| Q3 2015 | $34,079,000 | -61.4% | 1,037,419 | -17.7% | 0.01% | -55.6% |
| Q2 2015 | $88,191,000 | +25.5% | 1,261,134 | +23.0% | 0.02% | +20.0% |
| Q1 2015 | $70,252,000 | -0.4% | 1,025,579 | +6.5% | 0.02% | 0.0% |
| Q4 2014 | $70,547,000 | +5.0% | 962,569 | +2.8% | 0.02% | 0.0% |
| Q3 2014 | $67,180,000 | -0.4% | 936,039 | +0.3% | 0.02% | 0.0% |
| Q2 2014 | $67,465,000 | -0.3% | 933,124 | +1.5% | 0.02% | 0.0% |
| Q1 2014 | $67,659,000 | -61.2% | 919,534 | -63.3% | 0.02% | -25.0% |
| Q4 2013 | $174,464,000 | +98.3% | 2,508,468 | +87.3% | 0.02% | -9.1% |
| Q3 2013 | $87,980,000 | -89.4% | 1,339,320 | -88.8% | 0.02% | -80.2% |
| Q2 2013 | $828,614,000 | – | 11,962,090 | – | 0.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |